BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22958494)

  • 1. How many ways can a podocyte die?
    Tharaux PL; Huber TB
    Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
    Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
    Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
    Shankland SJ
    Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulatory proteins in podocyte health and disease.
    Marshall CB; Shankland SJ
    Nephron Exp Nephrol; 2007; 106(2):e51-9. PubMed ID: 17570940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
    Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocytes: a new player for glutamate signaling.
    Armelloni S; Li M; Messa P; Rastaldi MP
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2272-7. PubMed ID: 23018105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The podocyte in health and disease: insights from the mouse.
    Michaud JL; Kennedy CR
    Clin Sci (Lond); 2007 Jun; 112(6):325-35. PubMed ID: 17291194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
    Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R
    Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte loss involves MDM2-driven mitotic catastrophe.
    Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
    J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.